We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

256 hedge funds and large institutions have $5.32B invested in IVERIC bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 106 funds opening new positions, 58 increasing their positions, 69 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 15 → 40 (+25)

129% more call options, than puts

Call options by funds: $538M | Put options by funds: $234M

49% more capital invested

Capital invested by funds: $3.58B → $5.32B (+$1.74B)

45% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 73

15% more funds holding

Funds holding: 223 → 256 (+33)

16% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 69

Holders
256
Holders Change
+33
Holders Change %
+14.8%
% of All Funds
4.02%
Holding in Top 10
40
Holding in Top 10 Change
+25
Holding in Top 10 Change %
+166.67%
% of All Funds
0.63%
New
106
Increased
58
Reduced
69
Closed
73
Calls
$538M
Puts
$234M
Net Calls
+$303M
Net Calls Change
+$293M

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$206M
2
BCM
Beryl Capital Management
California
+$188M
3
Goldman Sachs
Goldman Sachs
New York
+$114M
4
TAL
TIG Advisors LLC
New York
+$103M
5
Fidelity International
Fidelity International
Bermuda
+$100M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$238M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$160M
3
DTC
Deep Track Capital
Connecticut
-$158M
4
American Century Companies
American Century Companies
Missouri
-$126M
5
RG
Redmile Group
California
-$102M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$52.2M +$870K +24,641 +2%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$48.6M -$5.31M -150,437 -11%
MB
28
MPM BioImpact
Massachusetts
$47.8M +$5.96M +168,971 +16%
Adage Capital Partners
29
Adage Capital Partners
Massachusetts
$45.8M +$38.3M +1,084,140 +1,372%
N
30
Nuveen
North Carolina
$39.9M -$6.08M -172,312 -15%
Charles Schwab
31
Charles Schwab
California
$39.1M +$585K +16,583 +2%
KCM
32
Kingdon Capital Management
New York
$38.6M -$2.57M -72,950 -7%
Norges Bank
33
Norges Bank
Norway
$37.6M +$24.2M +686,544 +256%
E
34
Ergoteles
New York
$34.6M +$31M +878,359 New
SCM
35
Segantii Capital Management
Hong Kong
$34.4M +$30.9M +875,000 New
SGCM
36
Sand Grove Capital Management
United Kingdom
$34M +$30.5M +865,399 New
CC
37
Carlson Capital
Texas
$32.8M +$29.5M +835,000 New
GCL
38
Glazer Capital LLC
New York
$32.5M +$29.2M +826,600 New
BC
39
Boxer Capital
California
$32.5M – – –
FTCM
40
First Trust Capital Management
Illinois
$30.6M +$27.5M +778,246 New
Hudson Bay Capital Management
41
Hudson Bay Capital Management
Connecticut
$30.4M +$18.2M +516,866 +202%
GF
42
Gabelli Funds
New York
$30.4M +$27.2M +771,489 New
EA
43
Emerald Advisers
Pennsylvania
$27.5M -$1.91M -53,986 -7%
GCIA
44
Gabelli & Co Investment Advisers
New York
$26.9M +$24.2M +684,950 New
Invesco
45
Invesco
Georgia
$25.8M -$48.4M -1,371,528 -68%
DCM
46
DAFNA Capital Management
California
$24.1M – – –
Marshall Wace
47
Marshall Wace
United Kingdom
$23.9M +$18.9M +536,361 +765%
Canada Pension Plan Investment Board
48
Canada Pension Plan Investment Board
Ontario, Canada
$23.3M +$20.9M +592,000 New
EMFAT
49
Emerald Mutual Fund Advisers Trust
Pennsylvania
$23M -$519K -14,717 -2%
Bank of New York Mellon
50
Bank of New York Mellon
New York
$22.1M +$435K +12,316 +2%
1
2
3 4 5

ISEE Hedge Fund Activity: Q2 2023 in Review

256 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2023, worth a combined $5.32B — up 49% from $3.58B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new ISEE positions and 73 closed out — a net gain of 33 holders — while 58 added to existing stakes and 69 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $206M. The largest seller was T. Rowe Price Associates, cutting an estimated $238M.

  • 256 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2023, up from 223 in Q1 2023.
  • Funds reported $5.32B of IVERIC bio, Inc. Common Stock stock for Q2 2023, up 49% quarter-over-quarter.
  • 106 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2023 and 73 closed out, a net change of +33 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2023 was UBS O'Connor, an estimated $206M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2023 was T. Rowe Price Associates, an estimated $238M sold.

Based on aggregated 13F filings for Q2 2023.